Healio

FibroScan after endoscopy found undiagnosed NAFLD, NASH

PHILADELPHIA — FibroScan screening for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis could significantly improve patient diagnosis and care, as data presented at the American ...
KUTV

Check Your Health: A simple non-invasive test can tell you if you have a fatty liver

KUTV — Fatty liver disease is a chronic liver disease and is a rapidly growing problem here in Utah. It’s important to catch this disease early with a simple, non-invasive test and then make the ...
Business Wire

Echosens and ChronWell Announce Exclusive Strategic Partnership Between FibroScan and LIVErHEALTHY to Improve Patient Outcomes and Cost Savings

WALTHAM, Mass. & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Echosens North America, a high-technology company offering the FibroScan ® portfolio of solutions, and ChronWell, a digital health and ...
The Herald-Dispatch

Marshall Health offering non-invasive testing for liver disease using latest FibroScan® technology

The Tri-State’s TRUSTED news source. Click here to stay informed and subscribe to Herald-Dispatch. Click #isupportlocal for more information on supporting our local journalists. SCOTT DEPOT, W.Va. — ...
The Grand Junction Daily Sentinel

FibroScan device simplifies local liver scans

Just a few years ago, Grand Junction gastroenterologist Dr. William Shields was administering a lot of biopsies to diagnose the level of scarring in a patient's liver. The process involves a needle ...
Morningstar

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

This milestone opens a path for FibroScan® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development WESTBOROUGH, Mass., Sept. 8, 2025 ...
Business Wire

Echosens Partners with Veteran-Owned Fidelis: Announces Addition of FibroScan to US Defense Logistics Agency’s Medical Equipment ECAT

WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, is pleased to announce that FibroScan has been added to the US Defense Logistics ...
Healio

Q&A: FAST score, other noninvasive tests help identify, stratify at-risk MASH patients

Please provide your email address to receive an email when new articles are posted on . Researchers recommended the FibroScan-AST score to target those at risk for MASH. The score should be used with ...
manilatimes

FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

This milestone opens a path for FibroScan® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development This is the first time the FDA is ...